用于预防偏头痛的Aimovig：这个新成员可能难以融入。

Aimovig for Migraine Prevention: The New Kid May Have Trouble Fitting in.

作者信息

Reinke Thomas

出版信息

Manag Care. 2018 Jul;27(7):10-11.

Abstract

Aimovig (erenumab-aooe), codeveloped by Amgen and Novartis, has been recently approved for the prevention of migraines. Its mechanism of action is different than other migraine medications. But perhaps more interestingly, it is the first drug recently developed specifically for migraine prevention.

摘要

由安进公司和诺华公司联合开发的依瑞奈尤单抗（Aimovig，erenumab-aooe）最近已被批准用于预防偏头痛。其作用机制与其他偏头痛药物不同。但或许更有趣的是，它是最近专门为预防偏头痛而研发的首款药物。